Trifecta Health, MD

Trifecta Health Medical Center is a private psychiatric practice founded by Dr. Edward Fruitman, M.D., operating from four Manhattan locations: Downtown (115 Broadway), Midtown (1430 Broadway), Central Park West, and the Upper East Side (30 East 60th Street). The practice provides psychiatric evaluation and medication management for a broad range of conditions, with particular depth in ADHD, depression, anxiety, bipolar disorder, and substance use disorders. Trifecta's clinical breadth extends beyond standard medication management to include TMS (transcranial magnetic stimulation) therapy — an FDA-approved, non-invasive brain stimulation treatment for treatment-resistant depression that has also shown efficacy for ADHD symptoms. TMS at Trifecta is directed toward the dorsolateral prefrontal cortex and is offered as an alternative or complement to pharmacotherapy for patients who have not responded adequately to medication. The availability of TMS at the same practice where a patient receives their psychiatric care simplifies the clinical coordination that would otherwise require referral to a separate TMS provider. The practice offers telehealth appointments in addition to its four in-person locations, expanding its geographic reach beyond Manhattan to serve patients across New York State. Telehealth ADHD consultations follow the same clinical protocol as in-person visits, with the same providers conducting evaluations and managing medications. For ADHD specifically, Trifecta provides comprehensive evaluation and can prescribe both stimulant (Adderall, Ritalin, Vyvanse) and non-stimulant (Strattera, Wellbutrin, Intuniv) medications. The practice's Manhattan footprint enables stimulant prescribing through established physician-patient relationships, which is a practical advantage over national telehealth platforms navigating DEA telehealth prescribing restrictions. Trifecta's pricing ($350 initial, $200 follow-up) is consistent with private Manhattan psychiatry rates and reflects a premium over national telehealth platforms. The practice is not positioned as a budget option — it serves patients who want a well-established private practice with in-person access, a prominent clinical founder, and advanced treatment options like TMS. Insurance acceptance varies and should be verified before booking. The practice provides psychiatric evaluation and medication management for a broad range of conditions, with particular depth in ADHD, depression, anxiety, bipolar disorder, and substance use disorders. Trifecta's clinical breadth extends beyond standard medication management to include TMS (transcranial magnetic stimulation) therapy — an FDA-approved, non-invasive brain stimulation treatment for treatment-resistant depression that has also shown efficacy for ADHD symptoms. TMS at Trifecta is directed toward the dorsolateral prefrontal cortex and is offered as an alternative or complement to pharmacotherapy for patients who have not responded adequately to medication. The availability of TMS at the same practice where a patient receives their psychiatric care simplifies the clinical coordination that would otherwise require referral to a separate TMS provider. The practice offers telehealth appointments in addition to its four in-person locations, expanding its geographic reach beyond Manhattan to serve patients across New York State. Telehealth ADHD consultations follow the same clinical protocol as in-person visits, with the same providers conducting evaluations and managing medications. For ADHD specifically, Trifecta provides comprehensive evaluation and can prescribe both stimulant (Adderall, Ritalin, Vyvanse) and non-stimulant (Strattera, Wellbutrin, Intuniv) medications. The practice's Manhattan footprint enables stimulant prescribing through established physician-patient relationships, which is a practical advantage over national telehealth platforms navigating DEA telehealth prescribing restrictions. Trifecta's pricing ($350 initial, $200 follow-up) is consistent with private Manhattan psychiatry rates and reflects a premium over national telehealth platforms. The practice is not positioned as a budget option — it serves patients who want a well-established private practice with in-person access, a prominent clinical founder, and advanced treatment options like TMS. Insurance acceptance varies and should be verified before booking.